Tata Chemicals share news, announcements and annual reports
NSE: TATACHEMBSE: 500770Chemicals & PetrochemicalsSmall Cap
Tata Chemicals Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1999
Last close ₹610.00up ₹14.40 (2.42%)BSE ₹609.40
Share price at the NSE close on 2 Nov 2026. Previous close ₹595.60.
2 Nov: open ₹602.00, high ₹618.90, low ₹598.55
52-week range of traded prices to 2 Nov 2026
₹570.05Low, 23 Oct 2026₹894.95High, 4 Nov 2025
- Next results date: the board meets on 7 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,540 Cr363rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.73
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.80%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −10.1%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1,956 crore of one-off items, the largest of them in the quarter to Mar 2026.
- −1.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 1.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.36
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 11,16,95835.0% delivered
Tata Chemicals board meetings
101 filed, newest first. Page 2 of 3.
Nov 2017
13 Nov · Board meeting
Jul 2017
May 2017
Feb 2017
9 Feb · Board meeting
8 Feb · Board meeting
Jan 2017
Nov 2016
22 Nov · Board meeting
Aug 2016
Jul 2016
May 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
Jan 2015
14 Jan · Board meeting
To consider and take on record the Financial Results of the Company for the third quarter ended December 31, 2014.
Oct 2014
27 Oct · Board meeting
To consider and approve the Financial Results of the Company for the second quarter and half year ended September 30, 2014.
Jul 2014
24 Jul · Board meeting
To consider and approve the Financial Results of the Company for the first quarter ended June 30, 2014.
May 2014
Jan 2014
Oct 2013
22 Oct · Board meeting
Inter-alia, to consider and approve the Financial Results of the Company for the second quarter and half year ended September 30, 2013.
Jul 2013
15 Jul · Board meeting
Inter-alia, to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2013.
May 2013
7 May · Board meeting
To consider and approve Audited Financial Results for the year ended March 31, 2013 and recommendation of dividend for the financial year 2012-13, if any.
Jan 2013
22 Jan · Board meeting
To consider and take on record the Financial Results of the Company, for the third quarter ended December 31, 2012.
Oct 2012
22 Oct · Board meeting
To consider and approve the Financial Results of the Company for the second quarter ended September 30, 2012.
Jul 2012
17 Jul · Board meeting
Inter-alia to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2012.
May 2012
30 May · Board meeting
Following decisions were taken at the meeting of the Board of Directors of the Company held on May 30, 2012: (1) Mr. Cyrus P. Mistry has been appointed as an Additional Director of the Company with effect from May 30, 2012; (2) Dr. Vijay Kelkar has been appointed as an Additional Director of the Company with effect from May 30, 2012; (3) The Annual General Meeting of the Company will be held on August 22, 2012.8 May · Board meeting
To consider and approve Audited Financial Results for the year ended March 31, 2012 and recommendation of dividend for the financial year 2011-12, if any.
Jan 2012
23 Jan · Board meeting
To consider and take on record the Financial Results of the Company, for the third quarter ended December 31, 2011.
Nov 2011
11 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 11, 2011 approved the Scheme of Amalgamation ('the Scheme') of Wyoming 1 (Mauritius) Private Limited (Wyoming 1) with the Company. Wyoming 1 is a wholly owned subsidiary of the Company with its registered office in Mauritius. The Appointed Date of the Scheme is January 01, 2012. Upon the Scheme coming into effect and in terms of the Scheme of amalgamation, all assets and liabilities of Wyoming 1 shall, under the provisions of Sections 391 to 394 of the Companies Act 1956 and pursuant to the Order of the High Court sanctioning the Scheme and upon compliance with the process specified in the Scheme, will be transferred to and vested in the Company and all shares of Wyoming 1 stand cancelled. No shares of the Company will be issued and allotted in lieu or exchange of the Equity Shares of Wyoming 1. The Scheme is subject to and conditional upon requisite approvals and sanctions being received thereof, including approvals and orders under Sections 391 and 394 of the Companies Act, 1956, as may be required in India and such regulatory approvals as may be required under Mauritius Companies Act.
Oct 2011
19 Oct · Board meeting
To consider and approve the Financial Results of the Company for the second quarter ended September 30, 2011.
Jul 2011
20 Jul · Board meeting
Inter-alia to consider and approve the Financial Results of the Company for the first quarter ended June 30, 2011.
May 2011
6 May · Board meeting
To consider and approve Audited Financial Results for the year ended March 31, 2011 and recommendation of dividend for the financial year 2010-11, if any,
Jan 2011
7 Jan · Board meeting
To consider and take on record the Financial Results of the Company, for the third quarter ended December 31,2010.
Oct 2010
15 Oct · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company, for its second quarter ended September 30, 2010.
Jul 2010
19 Jul · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company, for the first quarter ended June 30, 2010.
May 2010
11 May · Board meeting
To consider and approve Audited Financial Results for the year ended March 31, 2010 and recommendation of dividend for the financial year 2009-10, if any,
Jan 2010
14 Jan · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company for the third quarter ended December 31, 2009.
Oct 2009
15 Oct · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company for the Second quarter ended September 30, 2009.
Jul 2009
21 Jul · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company for the first quarter ended June 30, 2009.
May 2009
11 May · Board meeting
To consider and approve Audited Financial Results for the year ended March 31, 2009 and recommendation of dividend for the financial year 2008-09, if any.
Jan 2009
14 Jan · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company, for the third quarter ended December 31, 2008.
Oct 2008
10 Oct · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company, for the second quarter ended September 30, 2008.
Jul 2008
15 Jul · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company, for the First quarter ended June 30, 2008.
Jun 2008
5 Jun · Board meeting
To consider inter-alia, approval of Audited Financial Results for the year ended March 31, 2008 and recommendation of dividend for the financial year 2007-08.
Jan 2008
11 Jan · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the company, for the Third quarter ended December 31, 2007.
Oct 2007
22 Oct · Board meeting
Company has received conversion notice from 13 Bondholders, aggregating to US$ 38,460,000 for conversion. The Allotment Committee of the Board of Directors of Tata Chemicals Ltd. is scheduled to meet on October 22, 2007, to consider the conversion requests of FCCB Bondholders and to allot the shares accordingly.9 Oct · Board meeting
To consider inter-alia and take on record the Audited Financial Results of the Company for the second quarter/half year ended September 30, 2007.
Jul 2007
11 Jul · Board meeting
To consider inter-alia and take on record the Audited Financial Results for the first quarter ended June 30, 2007.
May 2007
16 May · Board meeting
To consider inter alia, approval of Audited Financial Results for the year ended March 31, 2007 and recommendation of dividend for the financial year 2006 - 07.